Literature DB >> 29277196

Can we confidently use ketamine as a clinical treatment for depression?

Colleen Loo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29277196     DOI： 10.1016/S2215-0366(17)30480-7

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  4 in total

Review 1.  Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses.

Authors:  Tácio de Mendonça Lima; Marília Berlofa Visacri; Patricia Melo Aguiar
Journal:  Eur J Clin Pharmacol       Date:  2021-10-27       Impact factor: 2.953

2.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.

Authors:  Dmitriy Matveychuk; Rejish K Thomas; Jennifer Swainson; Atul Khullar; Mary-Anne MacKay; Glen B Baker; Serdar M Dursun
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-11

3.  Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review.

Authors:  Danika Dai; Courtney Miller; Violeta Valdivia; Brian Boyle; Paula Bolton; Shuang Li; Steve Seiner; Robert Meisner
Journal:  BMC Psychiatry       Date:  2022-02-22       Impact factor: 3.630

4.  Characteristics of patients expressing an interest in ketamine treatment: results of an online survey.

Authors:  Jolien K E Veraart; Sanne Y Smith-Apeldoorn; Hayley Trueman; Marrit K de Boer; Robert A Schoevers; Rupert McShane
Journal:  BJPsych Open       Date:  2018-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.